442 related articles for article (PubMed ID: 2457207)
41. Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model.
Mezzanzanica D; Garrido MA; Neblock DS; Daddona PE; Andrew SM; Zurawski VR; Segal DM; Wunderlich JR
Cancer Res; 1991 Oct; 51(20):5716-21. PubMed ID: 1833054
[TBL] [Abstract][Full Text] [Related]
42. [Radiolocalization of human hepatoma with anti-human hepatoma monoclonal antibodies and its F(ab')2 in tumor-bearing nude mice].
Chen ZN
Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):566-8, 38. PubMed ID: 2559787
[TBL] [Abstract][Full Text] [Related]
43. Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy.
Kitamura K; Takahashi T; Yamaguchi T; Noguchi A; Noguchi A; Takashina K; Tsurumi H; Inagake M; Toyokuni T; Hakomori S
Cancer Res; 1991 Aug; 51(16):4310-5. PubMed ID: 1868453
[TBL] [Abstract][Full Text] [Related]
44. Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Matthews DC; Badger CC; Fisher DR; Hui TE; Nourigat C; Appelbaum FR; Martin PJ; Bernstein ID
Cancer Res; 1992 Mar; 52(5):1228-34. PubMed ID: 1531324
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
46. Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb 188Re-HAb18.
Lou C; Chen ZN; Bian HJ; Li J; Zhou SB
World J Gastroenterol; 2002 Feb; 8(1):69-73. PubMed ID: 11833074
[TBL] [Abstract][Full Text] [Related]
47. F(ab')2 fragments versus intact antibody--an isodose comparison.
Humm JL; Chin LM; Macklis RM
J Nucl Med; 1990 Jun; 31(6):1045-7. PubMed ID: 2189961
[No Abstract] [Full Text] [Related]
48. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
49. The effect of radioimmunotherapy using murine monoclonal antibody KIS1 on esophageal squamous cell carcinoma-bearing nude mice.
Fujii T; Yamana H; Toh Y; Toh U; Fujita H; Shirouzu K; Morimatsu M
Surg Today; 1997; 27(11):1026-34. PubMed ID: 9413055
[TBL] [Abstract][Full Text] [Related]
50. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of a remote radioiodination system for radioimmunotherapy.
Weadock KS; Sharkey RM; Varga DC; Goldenberg DM
J Nucl Med; 1990 Apr; 31(4):508-11. PubMed ID: 2324826
[TBL] [Abstract][Full Text] [Related]
52. Preparation, characterisation and tumour targeting of cross-linked divalent and trivalent anti-tumour Fab' fragments.
Casey JL; King DJ; Chaplin LC; Haines AM; Pedley RB; Mountain A; Yarranton GT; Begent RH
Br J Cancer; 1996 Nov; 74(9):1397-405. PubMed ID: 8912535
[TBL] [Abstract][Full Text] [Related]
53. Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM
Int J Cancer; 1989 Aug; 44(2):292-300. PubMed ID: 2759735
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
[TBL] [Abstract][Full Text] [Related]
55. [Radioimmunoimaging using F(ab')2 fragment of monoclonal antibodies against human alpha-fetoprotein].
Sakahara H; Endo K; Nakashima T; Koizumi M; Ohta H; Torizuka K; Okada K; Yoshida O; Nishi S
Kaku Igaku; 1985 Mar; 22(3):377-82. PubMed ID: 2410644
[No Abstract] [Full Text] [Related]
56. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.
Endo K; Kamma H; Ogata T
J Natl Cancer Inst; 1988 Aug; 80(11):835-42. PubMed ID: 3392743
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: dosimetry calculations incorporating cross-organ beta doses.
Ugur O; Kostakoglu L; Hui ET; Fisher DR; Garmestani K; Gansow OA; Cheung NK; Larson SM
Nucl Med Biol; 1996 Jan; 23(1):1-8. PubMed ID: 9004907
[TBL] [Abstract][Full Text] [Related]
58. Labeling monoclonal antibodies and F(ab')2 fragments with (111In) indium using cyclic DTPA anhydride and their in vivo behavior in mice bearing human tumor xenografts.
Powe J; Pak KY; Paik CH; Steplewski Z; Ebbert MA; Herlyn D; Ernst C; Alavi A; Eckelman WC; Reba RC
Cancer Drug Deliv; 1984; 1(2):125-35. PubMed ID: 6544629
[TBL] [Abstract][Full Text] [Related]
59. Radioimaging of experimental glioma grafts using F (ab')2-fragments of monoclonal antibodies.
Stavrou D; Glässner H; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
Anticancer Res; 1986; 6(5):897-903. PubMed ID: 3800333
[TBL] [Abstract][Full Text] [Related]
60. Immunological enhancement of a murine tumor allograft by passive alloantibody IgG and F(ab')2.
Kaliss N; Sinclair NR; Cantrell JL
Eur J Immunol; 1976 Jan; 6(1):38-42. PubMed ID: 971718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
